Boston Immune Technologies & Therapeutics
- Russell LaMontagne
Russell LaMontagne is the CEO at Boston Immune Technologies and Therapeutics. Previously, Russell was a Partner at Corinth Group.
Russell holds an MS from Yale University.
Org chart
Sign up to view 6 direct reports
Get started